Alendronic Acid
Back to searchMolecule Structure
Scientific Name
Alendronic Acid
Description of the Drug
Alendronic acid is a bisphosphonate drug that prevents osteoclastic bone resorption which is used for the prevention and treatment of osteoporosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00630
http://www.drugbank.ca/drugs/DB00630
Brand Name(s)
Binosto, Fosamax
Company Owner(s)
Cipla Ltd, Organon Llc, Watson Laboratories Inc, Picket Pharmaceuticals Inc, Merck And Co Inc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Ascend Therapeutics Us Llc, Hangzhou Minsheng Binjiang Pharmaceutical Co Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Farnesyl diphosphate synthase | SINGLE PROTEIN | INHIBITOR | CHEMBL1782 |
Clinical Trial(s)
Unichem Links
Atlas | alendronate | ||||
SureChEMBL | SCHEMBL18898 | ||||
PharmGKB | PA448082 | ||||
Human Metabolome Database | HMDB0001915 | ||||
DrugBank | DB00630 | ||||
PubChem: Thomson Pharma | 15196679 | ||||
PubChem | 2088 | 44400013 | |||
Mcule | MCULE-3180289877 | ||||
LINCS | LSM-5831 | ||||
Nikkaji | J363.022F | ||||
PDBe | 212 | ||||
BindingDB | 25313 | ||||
EPA CompTox Dashboard | DTXSID5022568 | ||||
DrugCentral | 112 | ||||
Brenda | 212814 | 5337 | |||
ChemicalBook | CB3380835 | ||||
Guide to Pharmacology | 3141 | ||||
rxnorm | ALENDRONIC ACID | ALENDRONATE SODIUM | FOSAMAX | ALENDRONATE | BINOSTO |
KEGG Ligand | C07752 | ||||
ChEBI | 2567 | ||||
ZINC | ZINC000003801919 |